The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Lethal Synergism between Influenza Virus and Streptococcus pneumoniae: Characterization of a Mouse Model and the Role of Platelet‐Activating Factor Receptor
Abstract
A lethal synergism exists between influenza virus and pneumococcus, which likely accounts for excess mortality from secondary bacterial pneumonia during influenza epidemics. Characterization of a mouse model of synergy revealed that influenza infection preceding pneumococcal challenge primed for pneumonia and led to 100% mortality. This effect was specific for viral infection preceding bacterial infection, because reversal of the order of administration led to protection from influenza and improved survival. The hypothesis that influenza up-regulates the platelet-activating factor receptor (PAFr) and thereby potentiates pneumococcal adherence and invasion in the lung was examined in the model. Groups of mice receiving CV-6209, a competitive antagonist of PAFr, had survival rates similar to those of control mice, and lung and blood bacterial titers increased during PAFr inhibition. These data suggest that PAFr-independent pathways are operative in the model, prompting further study of receptor interactions during pneumonia and bacteremia. The model of lethal synergism will be a useful tool for exploring this and other mechanisms underlying viral-bacterial interactions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The timing of infection with the 2 organisms in coinfection models affects outcomes.”
From Influenza virus primes mice for pneumonia from Staphylococcus aureus. (2011) · cites this paper as [23]
In the citing paper
“In the pneumococcal secondary infection model, influenza virus enhances the bacterial load of S. pneumoniae recovered from the lungs and blood of mice, and strain-specific differences between outcomes are directly related to the total bacterial lung load [23,32,33].”
From Influenza virus primes mice for pneumonia from Staphylococcus aureus. (2011) · cites this paper as [23]
In the citing paper
“Little to no enhancement of disease is seen if the bacterial infection precedes exposure to the virus or the organisms are encountered together [23].”
From Influenza virus primes mice for pneumonia from Staphylococcus aureus. (2011) · cites this paper as [23]
In the citing paper
“Roughly 3-10 days after viral infection, a proinflammatory state characterized by granulocyte and monocyte influx into the lungs amplifies host responses to bacteria, resulting in poor outcomes [23,25,43].”
From Influenza virus primes mice for pneumonia from Staphylococcus aureus. (2011) · cites this paper as [23]
In the citing paper
“There seems to be biphasic response to the virus that alters innate responses to the secondary bacterial pathogen.”
From Influenza virus primes mice for pneumonia from Staphylococcus aureus. (2011) · cites this paper as [23]
Citations
Cites
Principles and Practice of Infectious Diseases.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-818_5 · Cited by 12,045
Cundell, D. R., Gerard, N. P., Gerard, C. J., Idänpään‐Heikkilä, I., & TUOMANEN, E. I. (1995) · Nature · doi:10.1038/377435a0 · Cited by 741
The impact of influenza epidemics on mortality: introducing a severity index.
Simonsen, L., Clarke, M. J., Williamson, G. D., Stroup, D. F., Arden, N. H., & Schonberger, L. B. (1997) · American Journal of Public Health · doi:10.2105/ajph.87.12.1944 · Cited by 587
Options for the control of influenza III
Ada, G., Tannock, G. A., & Hampson, A. W. (1997) · Vaccine · doi:10.1016/s0264-410x(96)00191-0 · Cited by 587
STUDIES ON INFLUENZA IN THE PANDEMIC OF 1957-1958. II. PULMONARY COMPLICATIONS OF INFLUENZA*†
Louria, D. B., Blumenfeld, H. L., Ellis, J. T., Kilbourne, E. D., & Rogers, D. E. (1959) · Journal of Clinical Investigation · doi:10.1172/jci103791 · Cited by 479
The Impact of Influenza Epidemics on Hospitalizations
Simonsen, L., Fukuda, K., Schonberger, L. B., & Cox, N. J. (2000) · The Journal of Infectious Diseases · doi:10.1086/315320 · Cited by 476
Apoptosis: a mechanism of cell killing by influenza A and B viruses
Hinshaw, V. S., Olsen, C. W., Dybdahl-Sissoko, N., & Evans, D. T. (1994) · Journal of Virology · doi:10.1128/jvi.68.6.3667-3673.1994 · Cited by 424
Zhang, J., Mostov, K. E., Lamm, M. E., Nanno, M., Shimida, S.-I., Ohwaki, M., & TUOMANEN, E. I. (2000) · Cell · doi:10.1016/s0092-8674(00)00071-4 · Cited by 418
Pathogenesis of Pneumococcal Infection
TUOMANEN, E. I., AUSTRIAN, R. C., & Masure, H. R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505113321907 · Cited by 381
Respiratory viral infection predisposing for bacterial disease: a concise review.
Hament, J.-M., Kimpen, J. L. L., Fleer, A., & Wolfs, T. F. W. (1999) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.1999.tb01389.x · Cited by 306
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 419
Platelet Activating Factor (PAF): A Mediator of Inflammation
Upton, J. E. M., Grunebaum, E., Sussman, G., & Vadas, P. (2022) · BioFactors · doi:10.1002/biof.1883 · Cited by 79
Garcia, C. C., Russo, R. C., Guabiraba, R., Fagundes, C. T., Polidoro, R. B., Tavares, L. P., Salgado, A. P. C., Cassali, G. D., Sousa, L. P., Machado, A. V., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001171 · Cited by 79
Watson, M., Gilmour, R. E., Menzies, R., Ferson, M. J., McIntyre, P. B., & New South Wales Pneumococcal Network (2005) · Clinical Infectious Diseases · doi:10.1086/498897 · Cited by 79
The role of influenza in the severity and transmission of respiratory bacterial disease
Mina, M. J., & Klugman, K. P. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70131-6 · Cited by 84
Enhancement of immune responses to influenza vaccine (H3N2) by ginsenoside Re
Song, X., Chen, J., Sakwiwatkul, K., Li, R., & Hu, S. (2009) · International Immunopharmacology · doi:10.1016/j.intimp.2009.12.009 · Cited by 72
Viral–bacterial interactions in the respiratory tract
Bellinghausen, C., Rohde, G. G. U., Savelkoul, P. H. M., Wouters, E. F. �., & Stassen, F. R. M. (2016) · Journal of General Virology · doi:10.1099/jgv.0.000627 · Cited by 77
Viral Coinfections in Children With Invasive Pneumococcal Disease
Techasaensiri, B., Techasaensiri, C., Mejías, A., McCracken, G. H., & Ramilo, O. (2010) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181cdafc2 · Cited by 70
A Mouse Model of Lethal Synergism Between Influenza Virus and Haemophilus influenzae
Lee, L. N., Dias, P. B., Han, D., Yoon, S., Shea, A., Zakharov, V., Parham, D. M., & Sarawar, S. R. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090596 · Cited by 73
Meng, F., Wu, N., Nerlich, A. G., Herrler, G., Valentin‐Weigand, P., & Seitz, M. (2015) · Infection and Immunity · doi:10.1128/iai.00171-15 · Cited by 71
The role of respiratory viruses in the etiology of bacterial pneumonia
Lee, K. H., Gordon, A., & Foxman, B. (2016) · Evolution Medicine and Public Health · doi:10.1093/emph/eow007 · Cited by 73
Maternal Influenza Immunization and Prevention of Severe Clinical Pneumonia in Young Infants
Omer, S. B., Clark, D. R., Aqil, A. R., Tapia, M. D., Nunes, M. C., Kozuki, N., Steinhoff, M. C., Madhi, S. A., & Wairagkar, N. S. (2018) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001914 · Cited by 67
Host‐pathogen kinetics during influenza infection and coinfection: insights from predictive modeling
Smith, A. M. (2018) · Immunological Reviews · doi:10.1111/imr.12692 · Cited by 71
Influenza vaccination is associated with reduced severity of community-acquired pneumonia
Tessmer, A., Welte, T., Schmidt-Ott, R., Eberle, S., Barten, G., Suttorp, N., & Schaberg, T. (2011) · European Respiratory Journal · doi:10.1183/09031936.00133510 · Cited by 65
Influenza-Induced Inflammation Drives Pneumococcal Otitis Media
Short, K. R., Reading, P. C., Brown, L. E., Pedersen, J., Gilbertson, B. P., Job, E. R., Edenborough, K. M., Habets, M. N., Zomer, A., Hermans, P. W. M., et al. (2013) · Infection and Immunity · doi:10.1128/iai.01278-12 · Cited by 65
Prasso, J. E., & Deng, J. C. (2016) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2016.11.006 · Cited by 67
Aguilera, E. R., & Lenz, L. L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00105 · Cited by 65
Preventing and Treating Secondary Bacterial Infections with Antiviral Agents
McCullers, J. A. (2011) · Antiviral Therapy · doi:10.3851/imp1730 · Cited by 65
Self-citationStrom, T. S., Turner, S. J., Andreansky, S. S., Liu, H., Doherty, P. C., Srivastava, D. K., Cunningham, J. M., & Nienhuis, A. W. (2003) · Blood · doi:10.1182/blood-2002-11-3489 · Cited by 64
Influenza Viruses, Including Avian Influenza and Swine Influenza
Treanor, J. J. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00165-x · Cited by 63
Zanuzzo, F. S., Beemelmanns, A., Hall, J. R., Rise, M. L., & Gamperl, A. K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01009 · Cited by 62
MicroRNA-155 regulates host immune response to postviral bacterial pneumonia via IL-23/IL-17 pathway
Podsiad, A. B., Standiford, T. J., Ballinger, M. N., Eakin, R., Park, P. K., Kunkel, S. L., Moore, B. B., & Bhan, U. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00224.2015 · Cited by 63
Chen, W. H., Toapanta, F. R., Shirey, K. A., Zhang, L., Giannelou, A., Page, C., Frieman, M. B., Vogel, S. N., & Cross, A. S. (2011) · Immunology Letters · doi:10.1016/j.imlet.2011.10.009 · Cited by 64
Rameix‐Welti, M., Zarantonelli, L., Giorgini, D., Ruckly, C., Marasescu, M., van der Werf, S., Alonso, J., Naffakh, N., & Taha, M. (2009) · Infection and Immunity · doi:10.1128/iai.00155-09 · Cited by 61
The complex link between influenza and severe sepsis
Florescu, D. F., & Kalil, A. C. (2013) · Virulence · doi:10.4161/viru.27103 · Cited by 64
Induction and Role of Indoleamine 2,3 Dioxygenase in Mouse Models of Influenza A Virus Infection
Huang, L., Li, L., Klonowski, K., Tompkins, S. M., Tripp, R. A., & Mellor, A. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066546 · Cited by 59
Influenza and tuberculosis co‐infection: A systematic review
Walaza, S., Cohen, C., Tempia, S., Moyes, J., Nguweneza, A., Madhi, S. A., McMorrow, M., & Cohen, A. L. (2019) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12670 · Cited by 58
Disease Severity in Patients with Simultaneous Influenza and Bacterial Pneumonia
Seki, M., Kosai, K., Yanagihara, K., Higashiyama, Y., Kurihara, S., Izumikawa, K., Miyazaki, Y., Hirakata, Y., Tashiro, T., & Kohno, S. (2007) · Internal Medicine · doi:10.2169/internalmedicine.46.6364 · Cited by 57
Jia, L., Zhao, J., Yang, C., Liang, Y., Long, P., Liu, X., Qiu, S., Wang, L., Xie, J., Li, H., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03189 · Cited by 55
Subramaniam, R., Barnes, P. F., Fletcher, K., Boggaram, V., Hillberry, Z., Neuenschwander, P. F., & Shams, H. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit830 · Cited by 55
Interferon Lambda Inhibits Bacterial Uptake during Influenza Superinfection
Rich, H. E. A., McCourt, C. C., Zheng, W. Q., McHugh, K. J., Robinson, K. M., Wang, J., & Alcorn, J. F. (2019) · Infection and Immunity · doi:10.1128/iai.00114-19 · Cited by 55
Nguyen, T., Kyle, U. G., Jaimon, N., Tcharmtchi, M. H., Coss-Bu, J. A., Lam, F., Teruya, J., & Loftis, L. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e318260c7f8 · Cited by 54
Huber, V. C., Peltola, V. T., Iverson, A., & McCullers, J. A. (2010) · Journal of Virology · doi:10.1128/jvi.02621-09 · Cited by 54
Self-citationTobin, J. M., Nickolich, K. L., Ramanan, K., Pilewski, M. J., Lamens, K. D., Alcorn, J. F., & Robinson, K. M. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000067 · Cited by 55
Social contexts, syndemics, and infectious disease in northern Aboriginal populations
Herring, D. A., & Sattenspiel, L. (2007) · American Journal of Human Biology · doi:10.1002/ajhb.20618 · Cited by 54
Okamoto, S., Kawabata, S., Terao, Y., Fujitaka, H., Okuno, Y., & Hamada, S. (2004) · Infection and Immunity · doi:10.1128/iai.72.10.6068-6075.2004 · Cited by 54
Aebi, T., Weisser, M., Bucher, E., Hirsch, H. H., Marsch, S., & Siegemund, M. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-308 · Cited by 51
The role of influenza in the epidemiology of pneumonia
Shrestha, S., Foxman, B., Berus, J. M., van Panhuis, W. G., Steiner, C., Viboud, C. G., & Rohani, P. (2015) · Scientific Reports · doi:10.1038/srep15314 · Cited by 55
Robinson, K. M., Ramanan, K., Clay, M. E., McHugh, K. J., Rich, H. E. A., & Alcorn, J. F. (2017) · Mucosal Immunology · doi:10.1038/mi.2017.32 · Cited by 51
Prevention of influenza-related illness in young infants by maternal vaccination during pregnancy
Nunes, M. C., & Madhi, S. A. (2018) · F1000Research · doi:10.12688/f1000research.12473.1 · Cited by 52
Viral strategies predisposing to respiratory bacterial superinfections
Rossi, G. A., Fanous, H., & Colin, A. A. (2020) · Pediatric Pulmonology · doi:10.1002/ppul.24699 · Cited by 54
Chaussee, M. S., Sandbulte, H. R., Schuneman, M. J., DePaula, F. P., Addengast, L. A., Schlenker, E. H., & Huber, V. C. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.03.031 · Cited by 49
Alymova, I. V., Portner, A., Takimoto, T., Boyd, K. L., Babu, Y. S., & McCullers, J. A. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.398-405.2005 · Cited by 49
Self-citationInfection with human coronavirus NL63 enhances streptococcal adherence to epithelial cells
Gołda, A., Małek, N., Dudek, B., Żegleń, S., Wojarski, J., Ochman, M., Kucewicz-Czech, E. M., Zembala, M., Potempa, J., & Pyrć, K. (2011) · Journal of General Virology · doi:10.1099/vir.0.028381-0 · Cited by 50
The Role of Streptococcus pneumoniae in Community-Acquired Pneumonia
Anderson, R., & Feldman, C. H. (2016) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0036-1592074 · Cited by 48
A Critical, Nonlinear Threshold Dictates Bacterial Invasion and Initial Kinetics During Influenza
Smith, A. M., & Smith, A. P. (2016) · Scientific Reports · doi:10.1038/srep38703 · Cited by 48
Passariello, C., Schippa, S., Conti, C., Russo, P., Poggiali, F., Garaci, E., & Palamara, A. T. (2006) · Microbes and Infection · doi:10.1016/j.micinf.2005.09.013 · Cited by 47
de Vrankrijker, A. M. M., Wolfs, T. F. W., Ciofu, O., Høiby, N., van der Ent, C. K., Poulsen, S. S., & Johansen, H. K. (2009) · Journal of Medical Virology · doi:10.1002/jmv.21623 · Cited by 46
Benavides, J. A., Ovalle, O., Salvador, G. R., Gray, S., Isaacman, D. J., & Rodgers, G. L. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.03.054 · Cited by 46
Vaccine efficacy and T helper cell differentiation change with aging
Lefebvre, J. S., Lorenzo, E. C., Masters, A. R., Hopkins, J. W., Eaton, S. M., Smiley, S. T., & Haynes, L. (2016) · Oncotarget · doi:10.18632/oncotarget.9254 · Cited by 46
Duvigneau, S., Sharma-Chawla, N., Boianelli, A., Stegemann‐Koniszewski, S., Nguyễn, V. K., Bruder, D., & Hernandez-Vargas, E. A. (2016) · Scientific Reports · doi:10.1038/srep37045 · Cited by 46
Okamoto, S., Yoshii, H., Akagi, T., Akashi, M., Ishikawa, T., Okuno, Y., Takahashi, M., Yamanishi, K., & Mori, Y. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.09.051 · Cited by 46
Iovino, F., Brouwer, M. C., van de Beek, D., Molema, G., & Bijlsma, J. J. E. (2013) · Cellular Microbiology · doi:10.1111/cmi.12129 · Cited by 45
Sialidase and Sialyltransferase Inhibitors: Targeting Pathogenicity and Disease
Bowles, W., & Gloster, T. M. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.705133 · Cited by 45
Neuraminidase Inhibitors and their Role in Avian and Pandemic Influenza
Crusat, M., & de Jong, M. D. (2007) · Antiviral Therapy · doi:10.1177/135965350701200s07.1 · Cited by 45
McGillivary, G., Ray, W. C., Bevins, C. L., Munson, R. S., & Bakaletz, L. O. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.10.008 · Cited by 45
Seki, M., Higashiyama, Y., Tomono, K., Yanagihara, K., Ohno, H., Kaneko, Y., Izumikawa, K., Miyazaki, Y., Hirakata, Y., Mizuta, Y., et al. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2004.02481.x · Cited by 47
Blevins, L. K., Wren, J. T., Holbrook, B. C., Hayward, S. L., Swords, W. E., Parks, G. D., & Alexander‐Miller, M. A. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400529 · Cited by 44
Margolis, E. B., & Levin, B. R. (2007) · The Journal of Infectious Diseases · doi:10.1086/520934 · Cited by 44
Walther, E., Xu, Z., Richter, M., Kirchmair, J., Grienke, U., Rollinger, J. M., Krumbholz, A., Saluz, H. P., Pfister, W., Sauerbrei, A., et al. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00357 · Cited by 44
Rylance, J., Piters, W. A. A. D. S., Pojar, S., Nikolaou, E., German, E. L., Mitsi, E., Jochems, S. P., Carniel, B. F., Solórzano, C., Reiné, J., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201811-2081le · Cited by 45
Do specific virus–bacteria pairings drive clinical outcomes of pneumonia?
McCullers, J. A. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12093 · Cited by 47
Self-citationSpeshock, J. L., Doyon‐Reale, N., Rabah, R. M., Neely, M. N., & Roberts, P. C. (2007) · Infection and Immunity · doi:10.1128/iai.01943-06 · Cited by 44
Ishikawa, H., Fukui, T., Ino, S., Sasaki, H., Awano, N., Kohda, C., & Tanaka, K. (2016) · Virology · doi:10.1016/j.virol.2016.08.025 · Cited by 43
Lethal Synergism between Influenza and Streptococcus pneumoniae
Rudd, J. M. (2016) · Journal of Infectious Pulmonary Diseases · doi:10.16966/2470-3176.114 · Cited by 43
Mitchell, S. A., Mercado, E. L., Adelaja, A., Ho, J. Q., Cheng, Q. J., Ghosh, G., & Hoffmann, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01425 · Cited by 44
Influenza-Induced Oxidative Stress Sensitizes Lung Cells to Bacterial Toxin-Mediated Necroptosis
González-Juarbe, N., Riegler, A. N., Jureka, A. S., Gilley, R. P., Brand, J. D., Trombley, J. E., Scott, N. R., Platt, M. P., Dube, P. H., Petit, C. M., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108062 · Cited by 43
Omoush, S. A., & Alzyoud, J. A. M. (2022) · Pathogens · doi:10.3390/pathogens11040445 · Cited by 44
Sialidase‐Based Anti–Influenza Virus Therapy Protects against Secondary Pneumococcal Infection
Hedlund, M., Aschenbrenner, L. M., Jensen, K. A., Larson, J. L., & Fang, F. (2010) · The Journal of Infectious Diseases · doi:10.1086/651170 · Cited by 44
Trends in U.S. hospitalizations and inpatient deaths from pneumonia and influenza, 1996–2011
Chang, D. H., Bednarczyk, R. A., Becker, E. R., Hockenberry, J. M., Weiss, P., Orenstein, W. A., & Omer, S. B. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.12.003 · Cited by 42
Meliopoulos, V., de Velde, L.-A. V., van de Velde, N. C., Karlsson, E. A., Neale, G. A. M., Vogel, P., Guy, C. S., Sharma, S., Duan, S., Surman, S. L., et al. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005804 · Cited by 43
Weeks, J. N., Hurtig, H. R., Iverson, A., Schuneman, M. J., Webby, R. J., McCullers, J. A., & Huber, V. C. (2012) · Journal of Virology · doi:10.1128/jvi.00369-12 · Cited by 42
Self-citationA cooperativity between virus and bacteria during respiratory infections
Lalbiaktluangi, C., Yadav, M., Singh, P. K., Singh, A., Iyer, M., Vellingiri, B., Zomuansangi, R., Zothanpuia, Z., & Ram, H. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1279159 · Cited by 43
Ayala, V. I., Teijaro, J. R., Färber, D. L., Dorsey, S. G., & Carbonetti, N. H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019016 · Cited by 41
Ishaqui, A. A., Khan, A. H., Sulaiman, S. A. S., Alsultan, M. T., Khan, I., & Naqvi, A. A. (2020) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2020.1730180 · Cited by 41
Stegemann‐Koniszewski, S., Dahlberg, S., Kröger, A., Gereke, M., Bruder, D., Henriques‐Normark, B., & Gunzer, M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004840 · Cited by 42
Brockson, M. E., Novotny, L. A., Jurcisek, J. A., McGillivary, G., Bowers, M. R., & Bakaletz, L. O. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040088 · Cited by 40
Rosch, J. W., Iverson, A., Humann, J., Mann, B., Gao, G., Vogel, P., Mina, M. J., Murrah, K. A., Perez, A. C., Swords, W. E., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201202150 · Cited by 40
Self-citationImmunomodulators targeting MARCO expression improve resistance to postinfluenza bacterial pneumonia
Wu, M., Gibbons, J. G., DeLoid, G. M., Bedugnis, A. S., Thimmulappa, R. K., Biswal, S. S., & Kobzik, L. (2017) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00075.2017 · Cited by 42
Respiratory Bacteria Stabilize and Promote Airborne Transmission of Influenza A Virus
Rowe, H. M., Livingston, B., Margolis, E. B., Davis, A., Meliopoulos, V., Echlin, H., Schultz‐Cherry, S., & Rosch, J. W. (2020) · mSystems · doi:10.1128/msystems.00762-20 · Cited by 40
Yildiz, S., Bonifacio, J. P. P., Bergé, M., González‐Ruiz, V., Baud, D., Kloehn, J., Boal‐Carvalho, I., Schären, O. P., Schotsaert, M., Hathaway, L. J., et al. (2020) · eLife · doi:10.7554/elife.53581 · Cited by 41
Improving Therapeutic Strategies for Secondary Bacterial Pneumonia Following Influenza
McCullers, J. A., & English, B. K. (2008) · Future Microbiology · doi:10.2217/17460913.3.4.397 · Cited by 41
Self-citationThe regulatory T cells in anti-influenza antibody response post influenza vaccination
Wang, S.-M., Tsai, M.-H., Lei, H.-Y., Wang, J., & Liu, C. (2012) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.21117 · Cited by 39
Bruserud, Ø., Mosevoll, K. A., Bruserud, Ø., Reikvam, H., & Wendelbo, Ø. (2023) · Cells · doi:10.3390/cells12071003 · Cited by 38
Respiratory tract barrier dysfunction in viral-bacterial co-infection cases
Sumitomo, T., & Kawabata, S. (2024) · Japanese Dental Science Review · doi:10.1016/j.jdsr.2023.12.006 · Cited by 37
Cost-effectiveness of pneumococcal vaccination strategies for the elderly in Korea
Heo, J. Y., Seo, Y. B., Choi, W. S., Lee, J., Noh, J. Y., Jeong, H. W., Kim, W. J., Kim, M. J., Lee, H., & Song, J. Y. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177342 · Cited by 39
Ortigoza, M. B., Blaser, S. B., Zafar, M. A., Hammond, A. J., & Weiser, J. N. (2018) · mBio · doi:10.1128/mbio.02359-18 · Cited by 37
Viral–bacterial interactions–therapeutic implications
Deng, J. C. (2013) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12174 · Cited by 39
Mccullers, J. A., Iverson, A. R., Mckeon, R., & Murray, P. J. (2008) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540701477568 · Cited by 36
Self-citationThe influence of influenza virus infections on the development of tuberculosis
de Paus, R. A., van Crevel, R., van Beek, R., Sahiratmadja, E., Alisjahbana, B., Marzuki, S., Rimmelzwaan, G. F., van Dissel, J. T., Ottenhoff, T. H. M., & van de Vosse, E. (2013) · Tuberculosis · doi:10.1016/j.tube.2013.02.006 · Cited by 36
Wolter, N., Cohen, C., Tempia, S., Madhi, S. A., Venter, M., Moyes, J., Walaza, S., Kgokong, B. M., Groome, M. J., du Plessis, M., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit427 · Cited by 36
The host immune dynamics of pneumococcal colonization: Implications for novel vaccine development
Khan, M. N., & Pichichero, M. E. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/21645515.2014.979631 · Cited by 38
Boianelli, A., Sharma-Chawla, N., Bruder, D., & Hernandez-Vargas, E. A. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00060 · Cited by 37
Karlsson, E. A., Meliopoulos, V., van de Velde, N. C., de Velde, L.-A. V., Mann, B., Gao, G., Rosch, J. W., TUOMANEN, E. I., McCullers, J. A., Vogel, P., et al. (2017) · mBio · doi:10.1128/mbio.00889-17 · Cited by 36
Self-citationTrained immunity and host‐pathogen interactions
Peignier, A., & Parker, D. (2020) · Cellular Microbiology · doi:10.1111/cmi.13261 · Cited by 36
Macrophage adaptation in airway inflammatory resolution
Kaur, M., Bell, T., Salek‐Ardakani, S., & Hussell, T. (2015) · European Respiratory Review · doi:10.1183/16000617.0030-2015 · Cited by 38
Comparison of methods of temperature measurement in swine
HANNEMAN, S. K. G., Jesurum-Urbaitis, J. T., & Bickel, D. R. (2004) · Laboratory Animals · doi:10.1258/002367704323133682 · Cited by 36
Community-Acquired Pneumonia in Childhood
Popovsky, E. Y., & Florin, T. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-08-102723-3.00013-5 · Cited by 36
Wu, Y., Tu, W., Lam, K.-T., Chow, K., Ho, P., Guan, Y., Peiris, J. S. M., & Lau, Y. (2014) · Journal of Virology · doi:10.1128/jvi.02455-14 · Cited by 37
GP96 Drives Exacerbation of Secondary Bacterial Pneumonia following Influenza A Virus Infection
Sumitomo, T., Nakata, M., Nagase, S., Takahara, Y., Honda-Ogawa, M., Mori, Y., Akamatsu, Y., Yamaguchi, M., Okamoto, S., & Kawabata, S. (2021) · mBio · doi:10.1128/mbio.03269-20 · Cited by 35
Oyanedel, D., Lagorce, A., Bruto, M., Haffner, P., Morot, A., Labreuche, Y., Dorant, Y., Divonne, S. D. L. F., Delavat, F., Inguimbert, N., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2305195120 · Cited by 34
Metadata
- Authors
- McCullers, J. A., & Rehg, J. E.
- Affiliations
- St. Jude Children's Research Hospital (US)
- ORCID
- Rehg, Jerold E.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-08
- Volume
- 186
- Issue
- 3
- Pages
- 341-350
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2105680176
- Cited by
- 423
- References
- 48
- Citations by year
- 2026: 3 · 2025: 12 · 2024: 9 · 2023: 16 · 2022: 17 · 2021: 20 · 2020: 23 · 2019: 26 · 2018: 18 · 2017: 17 · 2016: 31 · 2015: 23 · 2014: 32 · 2013: 32 · 2012: 20
- FWCI
- 7.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (1k08ai049178-01)
- National Cancer Institute (CA21765, P30CA021765)
- National Institute of Allergy and Infectious Diseases (AI-49178)
- Topics
- Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
- Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
- Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
- Keywords
- influenza virus, Streptococcus pneumoniae, secondary bacterial pneumonia, platelet-activating factor receptor, CV-6209, bacteremia, mouse model, host-pathogen interaction
- MeSH terms
- Animals, Disease Models, Animal, Female, Lung, Mice, Inbred BALB C, Orthomyxoviridae, Orthomyxoviridae Infections, Platelet Membrane Glycoproteins, Pneumonia, Pneumococcal, Pyridinium Compounds, Receptors, Cell Surface, Streptococcus pneumoniae, Receptors, G-Protein-Coupled, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review